News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5 Michael O'Riordan July 07, 2020
News Conference News EuroPCR 2020 DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions Todd Neale June 30, 2020
News Conference News TVT 2020 Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform Yael L. Maxwell June 26, 2020
News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Opinion Conversations in Cardiology Conversations in Cardiology: Uncovered Struts on OCT After 12 Years? March 27, 2020
News Daily News Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS Yael L. Maxwell March 10, 2020
News Daily News Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk Yael L. Maxwell March 03, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Conference News CRT 2020 Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation Michael O'Riordan February 26, 2020
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Daily News SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE Michael O'Riordan February 03, 2020
News Opinion Conversations in Cardiology Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR? January 02, 2020